by healthadvances Posted on June 15, 2018 Commercial and Developmental Innovation: What Can We Learn from Gene Therapies? Read More
by healthadvances Posted on June 7, 2018 Early Access Programs in Europe: Differences and Opportunities in Germany, France and the UK Read More
by healthadvances Posted on May 11, 2018 Scaling the Mountain: Adoption Strategy for Digital Health Read More
by healthadvances Posted on May 3, 2018 Patient Advocacy Groups as a Strategy for Orphan Drug Access in the UK Read More
by healthadvances Posted on April 10, 2018 PCSK9 Inhibitors’ Battle for Reimbursement: Germany’s Decision and Implications in Other Countries Read More
by healthadvances Posted on April 4, 2018April 5, 2018 Three Models for Population Health Technology Read More
